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Preparations of phytomedicine has been used 
for health maintenance since ancient times. 
The phytomedicine’s posses a lot of 
therapeutic uses.Over the past century 
phytochemical and phyto-pharmacological 
sciences established the 
compositions,biological activities and health 
promoting benefits of  herbal extracts and their 
derivatives.It was observed that most of the 
biologically active phytoconstituents such as 
the flavonoids and terpenoids are of highly 
polar nature or water soluble molecules.These 
highly water soluble constituents are poorly 
absorbed due to their poor lipid solubility,thus 
creating a hurdle to cross the highly lipid-rich 
biological membrane,which finally results in 
poor bioavailability.Many approaches have 
been developed for improving the 
bioavailability such as inclusion of  solubility 
and bioavailability enhancers,structural 
modification and entrapement with lipophilic 
carriers[1-3].One such approach is the 
phytosome technology.The phytosome 
technology is a novel approach developed by 
Indena  in an attempt to combat the issue of  
 
poor bioavailability.The term “phyto” means 
plant and “some” means cell like.This novel 
preparation comprises of incorporating a 
standardized plant extract into phospholipids 
to produce lipid compatible molecular 
complexes with enhanced absorption and 
bioavailability.The phytosome process 
produces a little cell whereby the valuable 
plant extracts are protected from degradation 
by digestive enzymes and gut 
bacteria.Phospholipids are complex molecules 
responsible for formation of cell 
membranes.Phospholipids are lipid molecules 
in which the glycerol is bonded to two fatty 
acids and the remaining portion occupied by 
the phosphate group[6].The phospholipid 
mostly employed is phosphatidylcholine 
derived from soybean(Glycine 
max).Phytosomes are obtained by reacting 
phosphatidylcholine with herbal extracts in an 
aprotic solvent.Phytosomes posses improved 
pharmacokinetic and pharmacological 
properties as compared to the conventional 
preparation.The flavonoid and the terpenoid 
component’s of the herbal extract are able to 
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directly bind to the phosphatidylcholine moiety 
hence they are widely prepared.The 
phytosome process has been widely applied to 
herbal extract such as milk thistle (Silybum 
marianum),green tea (Thea sinensis)[4]. 
 
A NOVEL APPROACH: PHYTOSOME 
Phytosome results from reaction of 
stoichiometric amount of phospholipid mostly 
phosphatidylcholine with a standardized herbal 
extract in an aprotic 
solvent.Phosphatidylcholine is a bifunctional 
compound, the phosphatidyl moiety being 
lipophilic in nature which is the head of the 
bifunctional compound and the choline moiety 
which is the tail of the bifunctional compound 
being hydrophilic in nature. The choline moiety 
of the phosphatidylcholine bounds to the 
hydrophilic phytoconstituents, whereas the 
lipid soluble phosphatidyl portion then 
envelopes the choline bound complex. As a 
result a phyto-phospholipid complex is formed 
with a better lipid solubility. The polar 
phytoconstituents binds to the choline head by 
means of  a chemical bond. The term “phyto” 
means plant while “some” means cell like[8-10]. 
The phytosome technology produces a little 
micro sphere or little cell, which protects the 
plant extract or its active constituent from 
destruction by gastric secretion and gut 
bacteria due to the gastroprotective property of 
phosphatidylcholine [6].Fig .1  
 
PREPARATION OF PHYTOSOME 
Phytosomes are prepared by reacting 3-2 
moles or preferably 1 mole of 
phosphatidylcholine with 1 mole of active 
phytoconstituents mostly the flavonoids and 
the terpenoids in an aprotic solvent such as 
dioxane or acetone from which complex can 
be isolated by precipitation with non solvent 
such as aliphatic hydrocarbons or by 
lyophilization or by spray drying[49]. In the 
phyto-phospholipid complex formation the ratio 
between these two components is in the range 
of 0.5-2 moles  The most preferable ratio of  
phospholipid to phytoconstituents is 1:1[16-17] . 
The phospholipids mostly selected for 
phytosome preparations are selected from 
group consisting of soy lecithin (Glycine max); 
phosphatidylcholine, 
phosphatidylethanolamine, 
phosphatidyiserine, in which acyl group may 
be same or different and mostly derived from 
palmitic, stearic, oleic, linoleic acid. The 
phospholipid mostly selected is 
phophatidylcholine[2-3]. Spectroscopic 
techniques reveal’s that the molecules of the 
phytoconstituents are bonded to phospholipid 
moiety by means of a chemical bond[29-30]. The 
common stages for the preparation of 
phytosomes are mentioned in fig 2. 
 
PROPERTIES OF PHYTOSOME 
Phytosomes are complex between a natural 
phytoconstituents and natural phospholipids, 
like soy phospholipids mostly 
phosphatidylcholine. These complex results 
from the reaction of stoichiometric amounts of 
phospholipids with the phytoconstituents in an 
aprotic solvent[13-16].   
1. Phytosomes can accommodate the 
active principle that is anchored to the polar 
head of the phospholipids, which finally 
becomes an integral part of the membrane. 
The molecules are  
2. Phytosomes are advanced form of 
herbal drugs which are better absorbed, 
utilized and which finally leads to better results 
than conventional dosage form. The increased 
bioavailability has been demonstrated by the 
pharmacokinetic studies as well as by 
pharmacokinetic tests in experimental animals 
and human subjects. 
3. Phytosomes are lipophilic substances 
with definite melting point, freely soluble in 
non-polar solvents, and moderately soluble in 
fats. 
4. Phytosomes when treated with water 
assume a micellar shape, forming structure 
that resemble liposomes exhibiting 
fundamental difference.  
 
CHARACTERIZATION OF PHYTOSOME 
There are various factors such as the physical 
size, membrane permeability, percentage of 
entrapped solutes, chemical composition of 
the preparing materials which play a vital role 
in determining the behavior of phytosomes in 
physical and biological system. The following 
are the characterization techniques used for 
phytosomes in characterizing its physical 
attributes 
1. Transition temperature: The transition 
temperature of vesicular lipid system can be 
determinedby differential scanning 
calorimetry[25-26]. 
2.  Entrapement efficiency: The entrapement 
efficiency of a phytosomal formulation can be 
determined by subjecting the formulation to 
ultracentrifugation technique[24]. 
3. Vesicle size and Zeta potential: The particle 
size and zeta potential of phytosomes can be 
determined by dynamic light scattering which 
uses a computerized inspection system and 
photon correlation spectroscopy[28-29]. 
4. Surface tension activity measurement: The 
surface tension activity of drug in aqueous 
solution can be measured by ring method Du 
Nouy ring tensiometer[27]. 
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5. Spectroscopic evaluation: The 
spectroscopic evaluations are widely 
employed in order to confirm the formation of 
complex between phytoconstituents and the 
phospholipid moiety as well as to study the 
corresponding interaction between the two. 
The widely employed methods are 
5.11HNMR                                                                                                                                           
The NMR spectra are employed for estimating 
the complex formation between the active 
phytoconstituents and the phosphatidylcholine 
molecule. The NMR spectra of phytosome 
complex had been studied by Bombardelli. In 
nonpolar solvents there is amarked change in 
1H NMR signal originating from atoms involved 
in the formation of complex, without any 
summation of the signal peculiar to individual 
molecules. The signals from protons belonging 
to the phytoconstituents are broadened. In 
phospholipids there is broadening of signals 
while the singlet corresponding to the N-(CH3)3 
of choline undergoes an upfield shift[29-30]. 
5.213CNMR                                                                                                                                        
In the 13C NMR of the phytoconstituents and 
the stoichiometric complex with the 
phosphatidylcholine when recorded in C6D6at 
room temperature all the phytoconstituents 
carbons where invisible. The signals 
corresponding to the glycerol and choline 
portion are broadened and some are shifted, 
while most of the resonance of the fatty acids 
chains retain their original sharp line shape[29-
30]. 
5.3  FTIR                                                                                                                                  
The spectroscopic evaluation of the formed 
complex can be confirmed by FTIR simply by 
comparing the spectrum of the complex and 
the individual components and that of the 
mechanical mixtures. FTIR can also be 
considered as a valuable tool in confirming the 
stability of the phytosomal complex. The 
stability can be confirmed by comparing the 
spectrum of the complex in solid form with that 
of the spectrum of micro-dispersion in water 
after lyophilization at different times[29-30]. 
 
PHYTOSOMES AND LIPOSOMES : 
A COMPARISON 
Liposomes are also prepared by mixing 
suitable water soluble phytoconstituents in 
phosphatidylcholine in a definite ratio under 
suitable conditions. Here no chemical bond is 
formed, the phosphatidylcholine moiety just 
anchors the water soluble phytoconstituents 
as a result of which there may be hundreds or 
even thousands of phosphatidylcholine 
molecules surrounding the drug molecule. In 
case of phytosomes the phosphatidylcholine 
and the plant constituents form a complex in 
the ratio 1:1 or 2:1 and the process of 
phytosome formation involves chemical bond 
formation whereas the liposomes are 
completely devoid of the chemical bond 
formation between the phosphatidylcholine 
molecule and the phytoconstituents. Due to 
the lesser composition of the phospholipid 
content in case of phytosomes the 
phytosomes are more bioavailable and are 
absorbed to a better extent than the 
liposomes[16-18].Fig. 3 
 
ADVANTAGES OF PHYTOSOMES 
Phytosomes furnishes with the following 
advantages:[13-14] 
1. Phytosomes produces a little cell 
where the valuable components of herbal 
extracts are protected from destruction by 
digestive secretions and gut bacteria. 
2. It assures proper delivery of drug to 
the respective tissues. 
3. The nutrient safety of the herbal 
extracts need not be compromised by 
conveying the herbal drug as means of 
phytosomes. 
4. Dose requirement has been reduced 
due to the maximum absorption of chief 
constituents. 
5. Marked enhancement in the 
bioavailabilty of drug occurs. 
6. Entrapment efficiency is high and 
more over predetermined because drug itself 
is in conjugation with lipids in forming vesicles. 
7. There is no problem in drug 
entrapment while formulating phytosomes. 
8. Phytosomes shows better stability 
profile due to the formation of chemical bonds 
between phosphatidylcholine molecules and 
the phytoconstituents. 
9. Phosphatidylcholine used in 
formulating phytosome process besides acting 
as a carrier also nourishes the skin as it is an 
essential part of a cell membrane. 
10. Phytosomes are also superior to 
liposomes in skin care products. 
11. Phytosomes proves to be of 
significantly greater clinical benefit. 
12. Phosphatidylcholine used in 
preparation of phytosomes, besides acting as 
a carrier also acts as a hepatoprotective as a 
result it imparts a synergistic effect when 
hepatoprotective substances are employed. 
 
 APPLICATION OF PHYTOSOME 
Silymarin Phytosome                                                                                                              
Yanyu et al. prepared the silymarin phytosome 
and studied the pharmacokinetics in rats. In 
the study the bioavailability of silybin in rats 
was increased remarkably after oral 
administration of prepared silybin-phospholipid 
complex due to the impressive improvement of 
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the lipophilic property of silybin-phospholipid 
complex and which led to the improved 
biological effect of  silybin[4].                                                                                             
Tedesco et al. reported that silymarin 
phytosome exhibits better anti-hepatotoxic 
activity than silymarin alone and can play a 
vital role in protection against the toxic effects 
of aflatoxin B1 on performance of broiler 
chicks[21].                                                            
Mascarella et al. investigated that in one study 
of 232 patients with chronic hepatitis treated 
with silybin phytosome at a dose of 120 mg 
either twice daily or thrice daily for up to 120 
days, liver function returned to normal faster in 
patients taking silybin phytosome compared to 
a group of control[7].                                                                                                     
Bombardelli et al. reported silymarin 
phytosome in which silymarin was complexed 
with phospholipids. Phytosomes showed 
higher specific activity and a longer lasting 
action than single constituents with respect to 
the reduction of oedema, inhibition of 
myeloperoxidase activity, antioxidant and free 
radical scavenging activity[17].                                                    
Barzaghi et al. conducted a human study 
designed to assess the absorption of silybin 
when directly bounded to phosphatidylcholine. 
Plasma silybin levels were determined after 
administration of single oral dose of silybin 
phytosome and a similar amount of silybin 
from milk thistle in healthy volunteers. The 
results indicated that the absorption of silybin 
from silybin phytosome is approximately seven 
times greater as compared to the absorption of 
silybin from regular milk thistle[22-23].Grange et 
al. conducted a series of studies on silymarin 
phytosome, which contained a standardized 
extract from the seeds of S.marianum, 
administered orally and found out that it could 
protect the fetus from maternally ingested 
ethanol[23][42]. 
 
Phytosome of green tea                                                                                                         
Green tea leaves (Theasinensis)is 
characterized by prescence of a polyphenolic 
compound epigallocatechin 3-O-gallate as the 
key component. These compounds are potent 
modulators of  several biochemical process 
linked to the breakdown of homeostasis in 
major chronic-degenerative diseases such as 
cancer and atherosclerosis. Green tea also 
furnishes us with a number of beneficial 
activities such as antioxidant, anticarcinogenic, 
antimutagenic, hypocholesterolemic, 
cardioprotective effects. Inspite of such 
beneficial activities furnished by polyphenols 
from green tea extract the polyphenols suffer 
from the problem of poor bioavailability. The 
complexation of polyphenols derived from 
green tea with phospholipids strongly 
improves the oral bioavailability[5]. A study on 
absorption of phytosomal preparation was 
performed in healthy human volunteers along 
with non complexed green tea extract 
following oral administration. Over the study 
period of 6 hours the plasma concentration of 
total flavonoids was more than doubled when 
comparison was done between the 
phytosomal and the non-phytosomal 
preparation was done. Antioxidant capacity 
was measured as TRAP (Total Radical-
trapping Antioxidant Parameter). The peak 
antioxidant effect was a 20% enhancement 
and it showed that the phytosome formulation 
had about double the total antioxidant effect[9].                                                                                                                
Quercetin-phospholipid phytosomal 
complex                                                                          
Maiti et al. developed the quercetin-
phospholipid phytosomal complex by a simple 
and reproducible method and also showed 
that the formulation exerted better therapeutic 
efficacy as compared to the non-phytosomal 
conventional preparation in rat liver injury 
induced by carbon tetrachloride[51]. 
 
Phytosomes of grape seed                                                                                                   
Grape seedphytosome is composed of 
oligomeric polyphenols (grape 
proanthocyanidins or procyanidins from grape 
seed extract, Vitis vinifera) of varying 
molecular size complexed with phospholipids. 
The main properties of procyanidin flavonoids 
of grape seed are an increase in total 
antioxidant capacity and stimulation of  
physiological defenses of plasma, protection 
against ischemia/reperfusion induced 
damages in the heart,protective effects against 
atherosclerosis thereby offering marked 
protection against the cardiovascular system 
and other organs through a network of 
mechanism that extend beyond their 
antioxidant effect.                                                                                                          
In another study, rabbits were fed with a high 
cholesterol diet for 6 weeks, to markedly 
elevate their blood cholesterol level and to 
induce atherosclerotic lesions in their aortas 
and carotid arteries. One group of rabbit 
received grape seed phytosome in their feed 
for the first 6 weeks, then 4 weeks of high 
cholesterol diet. These developed significantly 
less aortic plaque than did the control group 
which received conventional standardized 
grape seed extract in similar regimen. In 
randomized human trial, young healthy 
volunteers received grape seed phytosome 
once daily for 5 days. The blood TRAP (Total 
Radical-trapping Antioxidant Parameter) was 
measured at several time intervals during 1st 
day, then also on 5th day. Already by 30 
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minutes after administration on 1stday, blood 
TRAP levels were significantly elevated over 
the control which received conventional 
standardized grape seed extract[31]. 
 
Phytosomes of curcumin                                                                                                     
Maiti et al. developed the phytosomes of 
curcumin (flavonoid from turmeric, Curcuma 
longa linn) and naringenin (flavonoid from 
grape, Vitis vinifera) in two different studies. 
The antioxidant activity of complex was 
significantly higher than pure curcumin in all 
dose levels tested. In the other study the 
developed phytosome of naringenin produced 
better antioxidant activity than the free 
compound with a prolonged duration of action, 
which may be due to decrease in the rapid 
elimination of the molecule from the body[47-48].  
 
Phytosomes of Gingko biloba leaves                                                                                 
Studies have shown that ginkgo phytosome 
(prepared from standardized extract of Ginkgo 
biloba leaves) produced better results 
compared to the conventional standardized 
extract from plant (GBE, 24% ginkgo flavones 
glycoside and 6% terpene lactones). In a 
bioavailability study conducted with healthy 
human volunteers the level of GBE 
constituents (flavonoids and terpenes) from 
the phytosomal form peaked after 3 hours and 
persisted longer for atleast 5 hours after oral 
administration. It was found that the 
phytosomal GBE produced a 2-4 times greater 
plasma concentration of terpenes than did the 
non-phytosomal GBE. Its major indication are 
cerebral insufficiency and peripheral vascular 
disorders and it can also ameliorate reduced 
cerebral circulations. Its improved oral 
bioavailability and good tolerability makes it 
the ideal ginkgo product even for long term 
treatment. Studies with ginkgo phytosomes in 
patients with peripheral vascular disorders 
have shown to produce 30-60%  greater 
improvement compared to regular 
standardized GBE[33].Studies were also 
conducted on gingko phytosome which yielded 
better result as compared to the conventional 
form. For conducting the aforesaid studies 
ginkgo phytosome was administered for 5 
days in guinea pigs, in whom the 
bronchoconstriction was induced by three 
different agonists (histamine, PAF and 
Acetylcholine). The bronchospastic inhibition 
was measured at the maximum peak, 
expressed as variations versus the basal 
values. The result indicated that ginkgo 
phytosome can not only counteract direct 
bronchoconstriction  but also it posses the 
tendency to reduce the TXA2 mediated 
bronchoconstriction of histamine and PAF as 
compared to the conventional forms, thus 
indicating the improved efficacy of ginkgo 
phytosome in combating the allergen induced 
bronchospasm. Studies have also proved the 
improved efficacy of ginkgo phytosome over 
the conventional standardized extract in 
protecting rat isolated hearts against ischemia. 
The above mentioned results clearly gives an 
indication about the upper hand that 
phytosome posses over the conventional 
preparations, thus proving it’s utility for herbal 
phytoconstituents[54].  
 
PATENTED TECHNOLOGIES RELATED TO 
PHYTOSOME 
A number of innovative process has been 
carried out in the field of phytosomes. The 
academic scientists are conducting a number 
of formulation research studies on phytosome, 
the studies are also conducted by industrial 
laboratories. These studies encompasses the 
current areas of research and the recent 
innovations that can be made possible in 
phytosomes. Some of the patented 
technologies of phytosome and other related 
technologies along with their applications and 




Phytosome are the advanced form of herbal 
extract which are better absorbed as 
compared to the conventional standardized 
herbal extract. These are the patented 
technologies developed by INDENA SPA 
Milan, Italy. A number of herbal standardized 
extract especially the polyphenolic and the 
terpenoids fraction are widely formulated as 
phytosome. Some of the marketed 
formulations are listed in the table. 2 
 
CONCLUSION 
A wide number of phytoconstituents are 
present in herbal drugs especially the 
flavonoidal and the terpenoidal fraction 
furnishes with a number of application. The 
poor absorption and the poor bioavailability 
associated with the polar phytoconstituents 
limits its use. These hindrances can be tackled 
by formulating an appropriate drug delivery 
system. Phospholipid based drug delivery 
system have been found promising for better 
and effective delivery of drug and can enhance 
the rate and extent of drug absorption across 
the lipoidal biomembrane. Phytosome are one 
of the phospholipid based drug delivery 
system with a better absorption and stability 
profile as compared to other phospholipid 
based drug delivery system. Phytosome can 
play a vital role in efficient delivery of 
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phytoconstituents such as the flavones and 
the xanthones. Apart from the aforesaid use 
phytosome also has a wide scope in 
cosmetics as well. Many areas of phytosome 
will be revealed in the future as part of their 
pharmaceutical use. 
                                                                  
 NOVEL APPROACHES FOR DELIVERY OF 
HERBAL CONSTITUENTS 
Liposomes                                                                                                                                
Liposomes are artificial microscopic vesicles 
consistiong of an aqueous core enclosed in 
one or more phospholipid layers, used to 
convey vaccines, drugs, enzymesor other 
substances to target cells or organs[46]. 
 
Nanoparticles 
Nanoparticles are particles of less than 100nm 
in diameter that exhibit new or enhanced size-
dependent properties compared with larger 





Microemulsion                                                                                                                             
 A thermodynamically stable dispersion of two 
immiscible liquids, stabilized by surfactants. A 
microemulsion is an emulsion whose particles 
are less than 1 micron in size[46]. 
 
Phytosome                                                                                                                    
It is a newly introduced patented technology 
developed to incorporate standardized plant 
extracts or water soluble phytoconstituents 
into phospholipids to produce lipid compatible 
molecular complexes they are also known as 
herbosome[46]. 
 
Transfersomes                                                                                                                                
 A transfersomes carrier is an artificially 
designed to be like cell vesicle or a cell 
engaged in exocytosis and thus suitable for 
controlled and potentially targeted drug 
delivery. Transfersome consist of 
phosphatidylcholine and cholate and are ultra 
deformable vesicles with enhanced skin 
















               Dissolve in solution containing organic solvent         








Formation of Phytosomal complex 
 
Isolation by precipitation 
(by lyophilization or spray drying) 
 
Fig. 2: Stages of Phytosome preparation[46] 
 
 
Fig. 3: Difference between phytosome and liposome 
The molecular organization of liposome upper segment 
The molecular organization of phytosome lower segment. 




Table 1: Patented Technologies of Phytosome 
 
Title of patent Innovation Patent no. Reference   
Phospholipids complexes 
EP/1844785 
of olive fruits or leaves 
extracts having improved 
bioavailabilty 
Phospholipids complexes of olive     
 
fruits or leaves extracts or their 
compositions containing it which 






Ginkgo biloba derivatives 
 
Compositions containing fractions 
derived from Ginkgo biloba useful 







Fatty acids monoesters of 
EP1690862 
sorbityl furfural and 
compositions for cosmetic 
and dermatological use 
 
 
Fatty acid monoesters of sorbityl       
 
furfural selected from two different 
series of compounds in which side 
chain is a linear or branched C3-C19 
alkyl radical optionally containing at 







Treatment of skin and 
US/2007 
wound repair with 
0015698 
thymosin β4 
Complexation of thymosin β4 along      
 









Isoflavone compositions exhibiting 
improved solubility, taste, colour 







An antioxidant preparation 
EP/12114084    37 
based on plant extracts for 
the treatment of circulation 
and adiposity prodlems 
                                                 
varicose veins, 
arteriosclerosis, high 
                                                 
blood pressure and 
haemorrhoids    
Preparations based on plant extracts     
 
which has an antioxidant effect and  
is particularly useful in treatment of  
circulation problems such as phlebitis, 
 
  
Complexes of saponins           
Complexes of saponins with 
natural   EP0283713 
with phospholipids and           
orsynthetic phospholipids 
posses  
pharmaceutical and high         
lipophilia and improved 
cosmetic compositions           
bioavailability and are 
suitable for  
containing them                      
use as active principle in  
                                                
pharmaceutical,dermatologic  
                                                
and cosmetic composition 











Fig. 4: NDDS for delivery of herbal constituents 
 
Table 2: Commercially Marketed Formulations  
 
Centella  phytosome           Triterpenes                         Centella         Leaf           Cicatrizing 
asiatica                                                                                                                    agent 
Crataegus phytosome       Vitexin-2-O-rhamnoside       Hawthorn        Flower       Antioxidant 
                                                                                      Flower 
Escin β-sitosterol                Escin β- sitosterol               Horse            Fruit          Antioedema 
phytosome                                                                     chestnut 
Gingkoselect                       Ginkgolides,bilobalides      Gingko           Leaf           Vasokinetic  
phytosome                                                                    biloba 
Ginselect                             Ginsenosides                       Panax          Rhizome    Adaptogenic 
phytosome                                                                       ginseng 
Ginkgo biloba terpenes       Ginkgolides,bilobalide             Ginkgo         Leaf          Soothing  
phytosome                                                                        biloba                            agent 
Ginkgo biloba dimeric        Dimeric flavonoids                   Ginkgo         Leaf          Lipolytic 
 phytosome                                                                       biloba 
Greenselect phytosome       Polyphenols                        Green tea      Leaf           Obesity 
Leucoselect phytosome       Polyphenols                        Vitis              Seed          Antioxidant 
                                                                                        vinifera  
Meriva                                 Curcuminiods                      Turmeric      Rhizome    Osteoarthritis   
PA2 phytosome                   Proanthocyanidin A2                  Horse           Bark         U.V.protectant 
                                                                                       chestnut  
Sericoside phytosome          Sericoside                         Terminalia     Bark         Anti-Wrinkles 
                                                                                       Sericea 
Siliphos                                Silybin                              Milk thistle     Seed     Hepatoprotective 
Silymarin phytosome           Silymarin                             Milk thistle      Seed     Hepatoprotective 
Virtiva                                  Ginkgoflavonglucosides      Ginkgo           Leaf          Vasokinetic 
                                                                                        Biloba 
Visnadex                              Visnadin                               Ammi          Seed         Vasokinetic 
                                                                                       Visnaga 
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